Gunda Georg
From Wikipedia, the free encyclopedia
Gunda I. Georg is a chemist who is currently a Professor of Medicinal Chemistry,[1] Regents Professor,[2] McKnight Presidential Chair, Robert Vince Endowed Chair at University of Minnesota and a former Co-Editor-in-Chief of American Chemical Society's Journal of Medicinal Chemistry.[3] Her research interests are total synthesis and semisynthesis as well as evaluating biologically active agents.[4] A cited expert in her field,[5] she was elected to the American Association for the Advancement of Science in 1996[6] and inducted in the Medicinal Chemistry Hall of Fame in 2017.[7] In 2019, she was announced as the 2020 winner and first woman to receive the Alfred Burger Award in Medicinal Chemistry (established by GlaxoSmithKline, now sponsored by Gilead[8]).[9] She along with chemists, Shameem Syeda and Gustavo Blanco, are leading researchers in male contraception.[10] Dr Georg also works with her research groups to conduct research on Alzheimer's disease, epilepsy and cancer experimental therapeutics.[11]
She earned her B.S. in 1975 and Ph.D. in 1980 from Philipps Universitat Marburg.[12]
Career
Georg is the Principal Investigator for a National Institutes of Health Center grant[13] for the Contraceptive Discovery, Development and Behavioral Research Center funded from 2017 to 2021. The grant work is in five interdisciplinary groups that are working on the discovery and development of non-hormonal male contraceptive agents and the investigation of contraceptive use.[14]
Georg's work is described in over 250 peer-reviewed publications [15] and she holds a number of patents.
She co-authored a book with Lednicer and Mitscher. Her medical contributions include Gamendazole, Lonidamine and Pregnenolyne derivatives.
